March 13, 2023
Pharmaceutical companies that have been facing multidistrict litigation over price-fixing claims are saying absolutely not to an attempt by the U.S. Department of Justice to access civil discovery materials for use in criminal prosecutions tied to the alleged scheme.
March 10, 2023
A Pennsylvania federal court signed off on settlements ending price-fixing claims from direct purchasers against Sun Pharmaceutical Industries Inc. and Taro Pharmaceutical Industries USA Inc. in ongoing multidistrict litigation over generic drug prices.
February 27, 2023
In a slew of rulings on Monday, a Pennsylvania federal court rejected most bids from drug companies seeking to nix sweeping price-fixing conspiracy allegations from a group of state attorneys general.
November 09, 2022
A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
June 07, 2022
The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.
May 25, 2022
A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.
May 20, 2022
Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.
May 11, 2022
Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.
May 10, 2022
A Pennsylvania federal court denied a dismissal bid Tuesday from drug companies in sprawling multidistrict litigation over alleged generic drug price-fixing, refusing to toss some state claims from end-payors while rejecting arguments that intervening authority should result in the claims being nixed.
April 07, 2022
After last week's $1.45 million settlement with Louisiana's attorney general, a pattern is emerging in Teva's efforts to deal its way out of sprawling price-fixing litigation that could put the generic-drug maker on the hook for about $100 million if it settles with every state enforcer.